Rise in COPCOV numbers continues; study to end recruitment 15 Dec
A global study examining the impact of chloroquine / hydroxychloroquine in preventing COVID-19, COPCOV has recruited 4,110 participants as of 1 Dec from sites in Benin, Côte d’Ivoire, Indonesia, Kenya, Mali, Nepal, Pakistan, Zambia, and closed sites in Thailand, Niger and the UK. COPCOV will end recruitment of new participants ~15 Dec 2021, with preliminary study results expected Q1 2022.
‘Working relationships’ across difference - a realist review of community engagement with malaria research
Vincent R. et al, (2022), Wellcome Open Research, 7, 13 - 13
Methaemoglobinaemia and the radical curative efficacy of 8-aminoquinoline antimalarials.
White NJ. et al, (2022), British journal of clinical pharmacology
Cross-sectional study of nutritional intake among patients undergoing tuberculosis treatment along the Myanmar-Thailand border.
Damji K. et al, (2022), BMJ Open, 12